Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Why have we not heard more about CURATE-AI?

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Why have we not heard more about CURATE-AI?

narmac

Mar 24, 2021 06:55AM

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Why have we not heard more about CURATE-AI?

in response to

Why have we not heard more about CURATE-AI?

narmac

posted on Mar 24, 2021 09:45AM

narmac, it's still in the Zenith Oncology Pipeline: All that's needed is money.

Oncology Pipeline

Prostate Cancer

Koo

2 Recommendations

Re: Why have we not heard more about CURATE-AI?

KOO-KOO2

Mar 24, 2021 10:50AM

Re: Why have we not heard more about CURATE-AI?

Toinv

Mar 25, 2021 11:12AM

Re: Why have we not heard more about CURATE-AI?

Nextblockbuster

Mar 25, 2021 05:40PM

Re: Why have we not heard more about CURATE-AI?

narmac

Mar 26, 2021 07:28AM

Reply New Message

Back To Forum List View

Please to post a reply